Mayne Pharma Group Limited Share Price

Equities

MYX

AU000000MYX0

Pharmaceuticals

Market Closed - Australian S.E. 11:41:03 07/06/2024 am IST 5-day change 1st Jan Change
4.72 AUD -1.05% Intraday chart for Mayne Pharma Group Limited -6.35% -23.25%

Financials

Sales 2024 * 38Cr 25Cr 2.1TCr Sales 2025 * 43Cr 28Cr 2.34TCr Capitalization 38Cr 25Cr 2.11TCr
Net income 2024 * -8.8Cr -5.79Cr -483.65Cr Net income 2025 * -1.9Cr -1.25Cr -104.42Cr EV / Sales 2024 * 0.79 x
Net cash position 2024 * 7.99Cr 5.26Cr 439.09Cr Net cash position 2025 * 5.31Cr 3.49Cr 291.57Cr EV / Sales 2025 * 0.78 x
P/E ratio 2024 *
-4.36 x
P/E ratio 2025 *
-19.4 x
Employees 967
Yield 2024 *
-
Yield 2025 *
-
Free-Float 70.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.05%
1 week-6.35%
Current month-6.35%
1 month-35.08%
3 months-32.57%
6 months-20.00%
Current year-23.25%
More quotes
1 week
4.68
Extreme 4.68
5.09
1 month
4.68
Extreme 4.68
7.21
Current year
4.68
Extreme 4.68
7.46
1 year
2.75
Extreme 2.75
7.46
3 years
0.22
Extreme 0.22
8.50
5 years
0.22
Extreme 0.22
12.90
10 years
0.22
Extreme 0.22
42.20
More quotes
Managers TitleAgeSince
Chief Executive Officer - 01/22/01
Director of Finance/CFO - 29/22/29
Chief Tech/Sci/R&D Officer - 01/15/01
Members of the board TitleAgeSince
Chairman 70 30/18/30
Director/Board Member 59 28/18/28
Chief Executive Officer - 01/22/01
More insiders
Date Price Change Volume
07/24/07 4.72 -1.05% 400,666
06/24/06 4.77 -3.25% 380,869
05/24/05 4.93 +0.61% 156,941
04/24/04 4.9 -2.20% 213,285
03/24/03 5.01 -0.60% 168,919

Delayed Quote Australian S.E., June 07, 2024 at 11:41 am IST

More quotes
Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.72 AUD
Average target price
6.89 AUD
Spread / Average Target
+45.97%
Consensus